$120.57 B
Share price
Change (1 day)
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

Market capitalization of Amgen (AMGN)

Market cap: $120.57 Billion

As of October 2022 Amgen has a market cap of $120.57 Billion. This makes Amgen the world's 83th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Amgen from 2001 to 2022

End of year Market Cap

Year Market cap Change
2022$120.57 B-4.85%
2021$126.71 B-5.33%
2020$133.85 B-6.11%
2019$142.56 B16.32%
2018$122.56 B-2.91%
2017$126.23 B16.06%
2016$108.76 B-11.13%
2015$122.39 B1.05%
2014$121.12 B40.7%
2013$86.08 B32.05%
2012$65.19 B15.83%
2011$56.28 B10%
2010$51.16 B-9.1%
2009$56.28 B-6.91%
2008$60.46 B19.78%
2007$50.48 B-36.62%
2006$79.64 B-17.48%
2005$96.52 B19.42%
2004$80.82 B1.9%
2003$79.31 B27.29%
2002$62.31 B5.57%
2001$59.02 B

End of Day market cap according to different sources

On Oct 2nd, 2022 the market cap of Amgen was reported to be:

$120.57 Billion
by Yahoo Finance
$120.57 Billion
by CompaniesMarketCap
$120.57 Billion
by Nasdaq
$120.57 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$429.50 B 256.22%๐Ÿ‡บ๐Ÿ‡ธ USA
$245.59 B 103.69%๐Ÿ‡บ๐Ÿ‡ธ USA
$237.29 B 96.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$307.23 B 154.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$38.74 B-67.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$77.32 B-35.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$30.01 B-75.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$151.79 B 25.89%๐Ÿ‡บ๐Ÿ‡ธ USA
$57.97 B-51.92%๐Ÿ‡ฌ๐Ÿ‡ง UK